Hefei Intai Pharmaceutical

Hefei Intai Pharmaceutical is a specialty pharmaceutical company based in Hefei, China, dedicated to the development and industrialization of high-end complex drug delivery systems. The company specializes in respiratory medicine, specifically focusing on dry powder inhalers (DPI) for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Intai Pharmaceutical operates state-of-the-art R&D centers and GMP-certified manufacturing facilities designed to meet international quality standards. Their portfolio includes several complex generic inhalation products that aim to provide high-quality, affordable alternatives to established global brands. Beyond respiratory health, the company explores advanced formulations for central nervous system and cardiovascular applications. Led by a team of experienced scientists, Intai is committed to advancing formulation science to improve patient access to critical therapies.